4//SEC Filing
Tyler Julie L. 4
Accession 0001415889-23-003064
CIK 0000001800other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:20 PM ET
Size
12.7 KB
Accession
0001415889-23-003064
Insider Transaction Report
Form 4
Tyler Julie L.
SENIOR VICE PRESIDENT
Transactions
- Tax Payment
Common shares without par value
2023-02-21$106.74/sh−341$36,398→ 41,156 total - Tax Payment
Common shares without par value
2023-02-19$106.74/sh−291$31,061→ 41,497 total - Sale
Common shares without par value
2023-02-22$103.24/sh−260$26,842→ 40,896 total - Award
Common shares without par value
2023-02-17+7,920→ 41,788 total - Award
Option (right to buy)
2023-02-17+31,236→ 31,236 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (31,236 underlying)
Holdings
- 9,513(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2023.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,412 on February 17, 2024, 10,412 on February 17, 2025 and 10,412 on February 17, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001867573
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:20 PM ET
- Size
- 12.7 KB